These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 33753455)

  • 1. Radium-223 Treatment Increases Immune Checkpoint Expression in Extracellular Vesicles from the Metastatic Prostate Cancer Bone Microenvironment.
    Vardaki I; Corn P; Gentile E; Song JH; Madan N; Hoang A; Parikh N; Guerra L; Lee YC; Lin SC; Yu G; Santos E; Melancon MP; Troncoso P; Navone N; Gallick GE; Efstathiou E; Subudhi SK; Lin SH; Logothetis CJ; Panaretakis T
    Clin Cancer Res; 2021 Jun; 27(11):3253-3264. PubMed ID: 33753455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosomal miRNAs from Prostate Cancer Impair Osteoblast Function in Mice.
    Furesi G; de Jesus Domingues AM; Alexopoulou D; Dahl A; Hackl M; Schmidt JR; Kalkhof S; Kurth T; Taipaleenmäki H; Conrad S; Hofbauer C; Rauner M; Hofbauer LC
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate cancer extracellular vesicles mediate intercellular communication with bone marrow cells and promote metastasis in a cholesterol-dependent manner.
    Henrich SE; McMahon KM; Plebanek MP; Calvert AE; Feliciano TJ; Parrish S; Tavora F; Mega A; De Souza A; Carneiro BA; Thaxton CS
    J Extracell Vesicles; 2020 Dec; 10(2):e12042. PubMed ID: 33408816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of exosomes in prostate cancer bone metastasis.
    Lv T; Li Z; Wang D; Guo X; Zhang X; Cao J; Wang Z
    Arch Biochem Biophys; 2023 Oct; 748():109784. PubMed ID: 37816420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating Changes in Immune Function and Bone Microenvironment During Radium-223 Treatment of Patients with Castration-Resistant Prostate Cancer.
    Dorff TB; Stein C; Kortylewski M; Posadas E; Synold T; Quinn D
    Cancer Biother Radiopharm; 2020 Sep; 35(7):485-489. PubMed ID: 32366119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The radiopharmaceutical radium-223 has immunomodulatory effects in patients and facilitates anti-programmed death receptor-1 therapy in murine models of bone metastatic prostate cancer.
    Saylor PJ; Kozin SV; Matsui A; Goldberg SI; Aoki S; Shigeta K; Mamessier E; Smith MR; Michaelson MD; Lee RJ; Duda DG
    Radiother Oncol; 2024 Mar; 192():110091. PubMed ID: 38224917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha particles as radiopharmaceuticals in the treatment of bone metastases: mechanism of action of radium-223 chloride (Alpharadin) and radiation protection.
    Cheetham PJ; Petrylak DP
    Oncology (Williston Park); 2012 Apr; 26(4):330-7, 341. PubMed ID: 22655525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination radium-223 therapies in patients with bone metastases from castration-resistant prostate cancer: A review.
    Cursano MC; Iuliani M; Casadei C; Stellato M; Tonini G; Paganelli G; Santini D; De Giorgi U
    Crit Rev Oncol Hematol; 2020 Feb; 146():102864. PubMed ID: 31986318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Exosomes in Prostate Cancer Metastasis.
    Akoto T; Saini S
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33805398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics of radium-223 and its effects on survival, proliferation and DNA damage in lymph-node and bone metastatic prostate cancer cell lines.
    Marques IA; Abrantes AM; Pires AS; Neves AR; Caramelo FJ; Rodrigues T; Matafome P; Tavares-da-Silva E; Gonçalves AC; Pereira CC; Teixeira JP; Seiça R; Costa G; Figueiredo A; Botelho MF
    Int J Radiat Biol; 2021; 97(5):714-726. PubMed ID: 33764249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BHLHE22 drives the immunosuppressive bone tumor microenvironment and associated bone metastasis in prostate cancer.
    Yin C; Wang M; Wang Y; Lin Q; Lin K; Du H; Lang C; Dai Y; Peng X
    J Immunother Cancer; 2023 Mar; 11(3):. PubMed ID: 36941015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of Radium-223 in Bone-metastatic Castration-resistant Prostate Cancer with and Without Homologous Repair Gene Defects.
    Isaacsson Velho P; Qazi F; Hassan S; Carducci MA; Denmeade SR; Markowski MC; Thorek DL; DeWeese TL; Song DY; Tran PT; Eisenberger MA; Antonarakis ES
    Eur Urol; 2019 Aug; 76(2):170-176. PubMed ID: 30293905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radium 223-Mediated Zonal Cytotoxicity of Prostate Cancer in Bone.
    Dondossola E; Casarin S; Paindelli C; De-Juan-Pardo EM; Hutmacher DW; Logothetis CJ; Friedl P
    J Natl Cancer Inst; 2019 Oct; 111(10):1042-1050. PubMed ID: 30657953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Principles, modalities and indications of the administration of Radium in cancers, focus on metastatic prostate cancer: State of arts].
    Bertolaso P; Leroy L; Gross-Goupil M; Aupee O; Ravaud A; Roubaud G; Cazeau AL; Le Moulec S
    Bull Cancer; 2017 Sep; 104(9):762-770. PubMed ID: 28797482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastatic Prostate Cancer and the Bone: Significance and Therapeutic Options.
    Gartrell BA; Coleman R; Efstathiou E; Fizazi K; Logothetis CJ; Smith MR; Sonpavde G; Sartor O; Saad F
    Eur Urol; 2015 Nov; 68(5):850-8. PubMed ID: 26153564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radium-223 dichloride for the treatment of metastatic prostate cancer.
    Turner PG; O'Sullivan J
    Expert Opin Pharmacother; 2014 Oct; 15(14):2105-11. PubMed ID: 25186336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Implications of Exosomal PD-L1 in Cancer Immunotherapy.
    Ayala-Mar S; Donoso-Quezada J; González-Valdez J
    J Immunol Res; 2021; 2021():8839978. PubMed ID: 33628854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radium-223 in combination with docetaxel in patients with castration-resistant prostate cancer and bone metastases: a phase 1 dose escalation/randomised phase 2a trial.
    Morris MJ; Loriot Y; Sweeney CJ; Fizazi K; Ryan CJ; Shevrin DH; Antonarakis ES; Pandit-Taskar N; Deandreis D; Jacene HA; Vesselle H; Petrenciuc O; Lu C; Carrasquillo JA; Higano CS
    Eur J Cancer; 2019 Jun; 114():107-116. PubMed ID: 31082669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exosomal mRNAs and lncRNAs involved in multiple myeloma resistance to bortezomib.
    Tang JX; Chen Q; Li Q; He YH; Xiao D
    Cell Biol Int; 2021 May; 45(5):965-975. PubMed ID: 33372728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radium-223 Inhibits Osseous Prostate Cancer Growth by Dual Targeting of Cancer Cells and Bone Microenvironment in Mouse Models.
    Suominen MI; Fagerlund KM; Rissanen JP; Konkol YM; Morko JP; Peng Z; Alhoniemi EJ; Laine SK; Corey E; Mumberg D; Ziegelbauer K; Käkönen SM; Halleen JM; Vessella RL; Scholz A
    Clin Cancer Res; 2017 Aug; 23(15):4335-4346. PubMed ID: 28364014
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.